KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Amortization of Deferred Charges (2019 - 2024)

Alnylam Pharmaceuticals' Amortization of Deferred Charges history spans 6 years, with the latest figure at $13.1 million for Q3 2024.

  • For Q3 2024, Amortization of Deferred Charges rose 27.95% year-over-year to $13.1 million; the TTM value through Sep 2024 reached $45.2 million, up 4.98%, while the annual FY2023 figure was $43.0 million, 4.61% up from the prior year.
  • Amortization of Deferred Charges reached $13.1 million in Q3 2024 per ALNY's latest filing, up from $9.7 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $13.1 million in Q3 2024 to a low of $9.4 million in Q1 2020.
  • Average Amortization of Deferred Charges over 5 years is $10.6 million, with a median of $10.3 million recorded in 2023.
  • Peak YoY movement for Amortization of Deferred Charges: dropped 12.1% in 2022, then rose 27.95% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $10.5 million in 2020, then fell by 3.98% to $10.1 million in 2021, then rose by 4.94% to $10.6 million in 2022, then decreased by 0.78% to $10.5 million in 2023, then increased by 24.45% to $13.1 million in 2024.
  • Per Business Quant, the three most recent readings for ALNY's Amortization of Deferred Charges are $13.1 million (Q3 2024), $9.7 million (Q2 2024), and $12.0 million (Q1 2024).